The Chemokine MIG is Associated with an Increased Risk of COVID-19 Mortality in Mexican Patients |
| |
| Authors: | Luis Antonio Ochoa-Ramirez1Rosalio Ramos-Payan2German Reynaldo Jimenez-Gastelum3Jose Rodriguez-Millan4Maribel Aguilar-Medina2Juan Jose Rios-Tostado1, 3Alfredo Ayala-Ham3Mercedez Bermudez5Juan Fidel Osuna-Ramos6Vicente Olimon-Andalon3Jesú s Salvador Velarde-Fé lix1, 3 |
| |
| Affiliation: | 1Genomic Medicine Laboratory, Culiacan General Hospital, Sinaloa, Mexico2Faculty of Chemical and Biological Sciences, Autonomous University of Sinaloa, Mexico3Faculty of Biology, Autonomous University of Sinaloa, Mexico4Department of Internal Medicine, Culiacan General Hospital, Sinaloa, Mexico5Faculty of Odontology, Autonomous University of Chihuahua, Mexico6Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Mexico City, Mexico |
| |
| Abstract: | Background: Coronavirus disease 2019 (COVID-19) is an emergent viral disease in which the host inflammatory response modulates the clinical outcome. Severe outcomes are associated with an exacerbation of inflammation in which chemokines play an important role as the attractants of immune cells to the tissues.Objective: To evaluate the relationship of the chemokines IL-8, RANTES, MIG, MCP-1, and IP-10 with COVID-19 severity and outcomes in Mexican patients.Methods: We analyzed the serum levels of IL-8, RANTES, MIG, MCP-1 and IP-10 in 148 COVID-19 hospitalized patients classified as mild (n=20), severe (n=61), and critical (n=67), as well as in healthy individuals (n=10), by flow cytometry bead array assay.Results: Chemokine levels were higher in patients than in the healthy individuals, but only MIG, MCP-1, and IP-10 increased according to the disease severity, showing the highest levels in the critical group. MIG, MCP-1, and IP-10 levels were also higher in COVID-19 patients with comorbidities such as renal disease, type 2 diabetes, and hypertension. Moreover, elevated MIG levels seem to be related to organic failure/shock, and an increased risk of death.Conclusions: Our results suggest that the increased levels of MCP-1, IP-10, and especially MIG might be useful in predicting severe COVID-19 outcomes and could be promising therapeutic targets. |
| |
| Keywords: | Chemokine COVID-19 IP-10 MCP-1 MIG |
|
| 点击此处可从《Iranian journal of immunology : IJI》浏览原始摘要信息 |
|
点击此处可从《Iranian journal of immunology : IJI》下载免费的PDF全文 |
|
